Laurence Busse M.D., M.B.A

Contact Information:


View Emory directory entry


Assistant Professor, Emory University

SOM: Medicine: Pulmonary

School Of Medicine

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 14

  1. 1
  2. 2


Angiotensin in Critical Care

by Anna Hall; Laurence W. Busse; Marlies Ostermann



COVID-19 and the RAAS-a potential role for angiotensin II?

by Laurence W. Busse; Jonathan H. Chow; Michael T. McCurdy; Ashish K. Khanna



Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study

by Lakhmir S Chawla; Laurence Busse; Ermira Brasha-Mitchell; Danielle Davison; Jacqueline Honiq; Ziyad Alotaibi; Michael G Seneff



Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial

by Kealy R. Ham; David W. Boldt; Michael T. McCurdy; Laurence W. Busse; Raphael Favory; Michelle N. Gong; Ashish K. Khanna; Stefan N. Chock; Feng Zeng; Lakhmir S. Chawla; George F. Tidmarsh; Marlies Ostermann



The effect of angiotensin II on blood pressure in patients with circulatory shock: A structured review of the literature

by Laurence Busse; Michael T. McCurdy; Osman Ali; Anna Hall; Huaizhen Chen; Marlies Ostermann



The use of angiotensin II in distributive shock

by Lakhmir S. Chawla; Laurence Busse; Ermira Brasha-Mitchell; Ziyad Alotaibi



Angiotensin i and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock

by Laurence Busse; Ashish Khanna; R Bellomo; RG Wunderink; H Szerlip; SW English; AM Deane; MT McCurdy; M Ostermann; PJ Young; DR Handisides; LS Chawla; GF Tidmarsh; TE Albertson



The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial

by David N. Hager; Michael H. Hooper; Gordon R. Bernard; Laurence Busse; E. Wesley Ely; Alpha A. Fowler; David F. Gaieski; Alex Hall; Jeremiah S. Hinson; James C. Jackson; Gabor D. Kelen; Mark Levine; Christopher J. Lindsell; Richard E. Malone; Anna McGlothlin; Richard E. Rothman; Kert Viele; David Wright; Jonathan Sevransky; Gregory Martin